Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05907499 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Decitabine for Poor Graft Function Post Allo-HSCT

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 18, 2023 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This randomized trial aims at validating the efficacy and safety of low-dose decitabine for PGF post allo-HSCT.
Trial Details
NCT Number NCT05907499
Lead Sponsor The First Affiliated Hospital of Soochow University
Conditions
(from sponsor)		 Poor Graft Function
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov